Cannara Biotech Inc. begins trading today on OTCQX under the symbol “LOVFF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on The OTCQX Market is ...
Eagle-eyed viewers, or just those who are as nosey as I am, may have spotted something particularly interesting towards the ...
He Jiankui spent three years in prison after creating gene-edited babies. Now back at work, he sees a greater opening for ...
Travere Therapeutics Stock (TVTX) is plummeting on news of a potential FDA delay for its kidney disease treatment ...
Stocktwits on MSN
Why did BCTX stock surge 50% today?
Following four doses of Bria-OTS as a single-agent therapy, the lung metastasis completely disappeared, the company said. ・he ...
FDA Breakthrough designation supports development of a point-of-care test for detecting folate receptor autoantibodies ...
A Delaware court has ruled that D&O insurers remain on the hook for later claims if they share underlying conduct with ...
Understand the role of reproductive biotech in overcoming biological limits in fertility treatments and enhancing success ...
NEWARK, CA / ACCESS Newswire / January 7, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today ...
32 Biosciences, a gastrointestinal (GI)-focused biotechnology company pioneering gut mucosal-immune science to prevent and treat GI diseases, today announced that it will officially launch its $40 ...
Our new study shows that feeding dogs can have a larger negative effect on the environment than the food their owners eat.
Multi-target license agreement grants Sidewinder access to Lonza's clinically validated ADC platform -- Sidewinder's pipeline of precision bispecific ADCs combined with Lonza's clinically validated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback